9:00am ET
Health and Healthcare
Major Pharma Short Interest Piles On
The September 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Companies
/Healthcare
Abbvie Inc
$255.48
▼ $2.67 (−1.03%) today
Markets closed · 11:30am ET
ABBV Coverage
Page 289:10am ET
Investing
Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More
The top analyst upgrades, downgrades and other research calls from Monday include Albermarle, Blue Apron, Box, Dish Network, GM, Transocean and Under Armour.
9:10am ET
Investing
Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More
The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest and Wendy's.
8:40am ET
Health and Healthcare
Major Pharma Short Interest Surges
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
4:08pm ET
Investing
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a mixed day for the U.S. broad markets with all major indices starting off positive, but quickly souring with the exception of the Nasdaq. Crude oil backed off after posting…
9:55am ET
Health and Healthcare
Short Sellers Run for Cover From Major Pharma
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks dropped.
8:40am ET
Health and Healthcare
Short Sellers Hike Bets in Major Pharma
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
1:20pm ET
Health and Healthcare
Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease
A blockbuster drug is about to get a chance to have even higher sales, as the FDA has expanded its approval of Imbruvica for the treatment of adult patients with chronic graft…
11:10am ET
Health and Healthcare
AbbVie Slips Despite Q2 Earnings Beat
AbbVie reported better-than-expected second-quarter financial results before the markets opened on Friday.
Chris Lange 8:55am ET
Health and Healthcare
Major Pharma Short Interest Takes a Big Step Back
The July 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
9:42am ET
Health and Healthcare
SunTrust Says Big Pharmaceuticals Have Multiple Catalysts for the Rest of 2017
A new report from SunTrust Robinson Humphrey indicates big pharmaceuticals may be the place to be for investors. Among the report's top picks: AbbVie, Eli Lilly, Merck, and Shire.
9:20am ET
Health and Healthcare
Major Pharma Short Sellers Become More Selective
The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
8:45am ET
Health and Healthcare
Short Sellers Run for Cover From Major Pharma
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks shrank.
8:55am ET
Health and Healthcare
Short Sellers Grow More Selective on Major Pharma
The May 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
1:35pm ET
Health and Healthcare
15 Companies Bracing for Big ASCO Reactions
24/7 Wall St. takes a look at the ASCO annual meeting each year and picks out the companies that could have the biggest boom or bust at the conference.